热门资讯> 正文
Organigram Global公布第四季度业绩
2025-12-16 19:03
- Organigram Global press release (OGI): Q4 net loss increased to C$38.0 million, compared to a net loss of C$5.4 million in Q4 Fiscal 2024. The increase in net loss from the comparative period is primarily due non-cash changes in fair value of derivative liabilities, preferred shares and other financial assets.
- Net revenue increased 79% to C$80.1 million, from C$44.7 million in the fourth quarter ended September 30, 2024 ("Q4 Fiscal 2024") primarily due to the contributions from the Motif acquisition, higher recreational cannabis sales and higher international sales.
More on Organigram Global Inc.
- Sell Village Farms And Buy Organigram
- Organigram Is No Longer A Bargain (Rating Downgrade)
- Earnings week ahead: FDX, NKE, MU, BB, CCL, ACN, and more
- Organigram CEO Beena Goldenberg extends contract to support ongoing search
- Seeking Alpha’s Quant Rating on Organigram Global Inc.
推荐文章
美股机会日报 | 贵金属“V”型反转！金银日内跌幅均收窄至2%，分析称其长期逻辑未改；特朗普豪掷120亿美元启动“金库计划”
一周IPO | 新消费IPO再受热捧！鸣鸣很忙首日涨近70%；大族数控、爱芯元智等五只新股正在招股中
打爆所有空头？Sandisk交出的“炸裂财报”再度引爆存储行情！周期或许远未见顶？
财报前瞻 | 4万亿美元市值迎大考！谷歌Q4财报能否为其“AI全栈”野心正名？
新股申购 | 两只新股今起招股！澜起科技一手入场费10796.80港元；爱芯元智一手入场费2848.44港元
华盛早报 | 特朗普今晚公布美联储新主席人选！沃什概率飙升至近8成；金银价格一度闪崩又回弹
美股机会日报 | Meta业绩亮眼盘前大涨9%！英伟达、微软等巨头被曝将向OpenAI投资600亿美元
港股突破28000点，接下来该如何布局？这三大方向尤获机构、北水青睐（附股）
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
